A new RXR agonist, HX630, suppresses intimal hyperplasia in a mouse blood flow cessation model
- 1 November 2006
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 41 (5) , 885-892
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 33 references indexed in Scilit:
- Synthetic Retinoid Am80 Reduces Scavenger Receptor Expression and Atherosclerosis in Mice by Inhibiting IL-6Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Attenuation of Graft Arterial Disease by Manipulation of the LIGHT PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- LR11, an LDL Receptor Gene Family Member, Is a Novel Regulator of Smooth Muscle Cell MigrationCirculation Research, 2004
- RXR-induced TNF-α suppression is reversed by morphine in activated U937 cellsJournal of Neuroimmunology, 2004
- Rev‐erbα upregulates NF‐κB‐responsive genes in vascular smooth muscle cellsFEBS Letters, 2004
- Crucial role of nuclear factor-κB in neointimal hyperplasia of the mouse carotid artery after interruption of blood flowAtherosclerosis, 2003
- Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-δ and Peroxisome Proliferator-Activated Receptor-γCirculation Research, 2002
- Effect of Estrogen and Progesterone on Gene Expression of Growth Regulatory Molecules and Proto-Oncogene in Vascular Smooth Muscle Cells.Endocrine Journal, 2000
- Regulation of Retinoidal Actions by Diazepinylbenzoic Acids. Retinoid Synergists Which Activate the RXR−RAR HeterodimersJournal of Medicinal Chemistry, 1997
- Mitogenic activity of interferon gamma on growth-arrested human vascular smooth muscle cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992